News

Filter

Current filters:

SandozLicensing

1 to 9 of 12 results

Sandoz to commercialize Taiwan Liposome’s antifungal

Sandoz to commercialize Taiwan Liposome’s antifungal

19-12-2013

Taipei-based biopharmaceutical company Taiwan Liposome Company has entered into a collaboration agreement…

Amphotericin BAntibiotics and Infectious diseasesAsia-PacificGenericsLicensingNovartisSandozTaiwan Liposome

Apricus expands Vitaros deal with Novartis unit

Apricus expands Vitaros deal with Novartis unit

16-12-2013

USA-based Apricus Biosciences has expanded its exclusive license agreement with Hexal AG, an affiliate…

Apricus BioscienceEuropeLicensingMen's HealthNovartisPharmaceuticalSandozVitaros

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

03-12-2013

UK drugmaker Shire says that its subsidiary Shire US Inc has entered into an agreement to supply an authorized…

Adderall XRGenericsLicensingNeurologicalNorth AmericaNovartisSandozShire

Avanir agrees settlement with Sandoz over Nuedexta

14-08-2013

US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with Swiss…

Avanir PharmaceuticalsGenericsLicensingNeurologicalNorth AmericaNuedextaPharmaceuticalSandoz

Apricus collaborates with Sandoz for ED drug

17-02-2012

San Diego, USA-based Apricus Biosciences (Nasdaq: APRI) said yesterday that its wholly-owned subsidiary…

Apricus BioscienceEuropeLicensingMen's HealthNovartisPharmaceuticalReproductiveSandozVitaros

Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello allergy immunotherapy

05-08-2011

There was another boost for UK inhalation product developer Vectura (LSE: VEC), which announced this…

ALK AbelloGenericsLicensingMerck & CoNovartisPharmaceuticalResearchRespiratory and PulmonarySandozVectura

1 to 9 of 12 results

COMPANY SPOTLIGHT

Menarini

Back to top